Notice of Special Interest: Kidney Precision Medicine  Technology Development and Translation
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-21-007.html
december 2, 2020pa-20-260 - phs 2020 omnibus solicitation of the nih, cdc and fda for small business innovation research grant applications (parent sbir [r43/r44] clinical trial not allowed)pa-20-265 - phs 2020-2 omnibus solicitation of the nih for small business technology transfer grant applications (parent sttr [r41/r42] clinical trial not allowed)pa-20-262 - phs 2020-2 omnibus solicitation of the nih, cdc, and fda for small business innovation research grant applications (parent sbir [r43/r44] clinical trial required)national institute of diabetes and digestive and kidney diseases (niddk)this nosi intends to encourage small businesses to translate kidney precision medicine discoveries and technologies. background recent gains in access to kidney tissue and bio-samples and advances in multi-scale interrogation of human tissue and single cells have set the stage for precision medicine to be applied to kidney disease. specifically, several cohort studies have included kidney biopsies [e.g., the kidney precision medicine project (kpmp) and the nephrotic syndrome study network (neptune)], and research consortia have advanced novel tools and technologies to interrogate bio-samples and released multi-omic data to the public. these bio-samples, technology, and data offer opportunities for technology development and translational research in the area of kidney precision medicine.objectives proposed technologies are expected to support efforts in kidney precision medicine. example technologies include, but are not limited to:supporting kidney precision medicinetranslation of kidney precision medicine discoveries and technologiesprojects must be within the mission of the niddk: https://www.niddk.nih.gov/about-niddk/research-areas.application and submission informationthis notice applies to due dates on or after january 5, 2021 and subsequent receipt dates through september 5, 2023.submit applications for this initiative using one of the following funding opportunity announcements (foas) or any reissues of these announcement through the expiration date of this notice.all instructions in the sf424 (r&r) application guide and the funding opportunity announcement used for submission must be followed, with the following additions:applications nonresponsive to terms of this nosi will not be considered for the nosi initiative.scientific/research contact(s)daniel gossett, ph.d. national institute of diabetes and digestive and kidney diseases (niddk) telephone: 301-594-7723 email: daniel.gossett@nih.govpeer review contact(s)examine your era commons account for review assignment and contact information (information appears two weeks after the submission due date).financial/grants management contact(s)ms. pamela love national institute of diabetes and digestive and kidney diseases (niddk) telephone: 301-435-6198 email: lovepa@mail.nih.govweekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.